Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2012
  • Online publication date: January 2013

Chapter 12 - Restless legs syndrome, periodic limb movements in sleep, and vascular risk factors

Summary

Anecdotal recognition of the relationship between sleep apnea and atrial fibrillation has recently given way to more rigorous observational data. The risk of recurrence after atrial fibrillation interventions has also been studied longitudinally. There are numerous pathophysiological mechanisms that may link sleep apnea to atrial fibrillation. One of the most important mechanisms may be the significant changes, both acute and chronic, in autonomic tone that occur with obstructive apneas. Most observational data suggest that the success rates of atrial fibrillation interventions, such as cardioversions and ablation, are significantly improved for patients whose sleep apnea is treated. Epidemiological studies suggest that sleep apnea is a risk factor for new-onset atrial fibrillation, and that its presence reflects a poorer prognosis after atrial fibrillation interventions. Randomized controlled trials are necessary to clarify the effects of sleep apnea therapy on atrial fibrillation outcomes in individuals and communities.

References

1. AllenRP, PicchiettiD, HeningWA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101–19.
2. AllenRP, WaltersAS, MontplaisirJ, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005; 165: 1286–92.
3. InnesKE, SelfeTK, AgarwalP. Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med 2011; 12: 623–34.
4. LugaresiE, CoccagnaG, GambiD, et al. A propos de quelques manifestations nocturnes myocloniques (nocturnal myoclonus de Symonds). Rev Neurol 1966; 115: 547–55.
5. The International Classification of Sleep Disorders. Diagnostic and Coding Manual. 2nd edn. Westchester, IL: American Academy of Sleep Medicine, 2005.
6. LeeSJ, KimJS, SongIU, et al. Poststroke restless legs syndrome and lesion location: anatomical considerations. Mov Disord 2009; 24: 77–84.
7. WaltersAS, MoussouttasM, SiddiquiF, et al. Prevalence of stroke in restless legs syndrome: initial results point to the need for more sophisticated studies. Open Neurol J 2010; 4: 73–7.
8. PortaluppiF, CortelliP, Calandra BuonauraG, et al. Do restless legs syndrome (RLS) and periodic limb movements of sleep (PLMS) play a role in nocturnal hypertension and increased cardiovascular risk of renally impaired patients?Chronobiol Int 2009; 26: 1206–21.
9. LindnerA, FornadiK, LazarAS, et al. Periodic limb movements in sleep are associated with stroke and cardiovascular risk factors in patients with renal failure. J Sleep Res 2012; 21: 297–307.
10. La MannaG, PizzaF, PersiciE, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant 2011; 26: 1976–83.
11. UlfbergJ, NystromB, CarterN, et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001; 16: 1159–63.
12. OhayonMM, RothT. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002; 53: 547–54.
13. PhillipsB, HeningW, BritzP, et al. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006; 129: 76–80.
14. MallonL, BromanJE, HettaJ. Restless legs symptoms with sleepiness in relation to mortality: 20-year follow-up study of a middle-aged Swedish population. Psychiatry Clin Neurosci 2008; 62: 457–63.
15. MöllerC, WetterTC, KösterJ, et al. Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care population. Sleep Med 2010; 11: 161–6.
16. RothdachAJ, TrenkwalderC, HaberstockJ, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 2000; 54: 1064–8.
17. HoglB, KiechlS, WilleitJ, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 2005; 64: 1920–4.
18. WinkelmanJW, FinnL, YoungT. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006; 7: 545–52.
19. WinkelmanJW, ShaharE, ShariefI, et al. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008; 70: 35–42.
20. WesstromJ, NilssonS, Sundstrom-PoromaaI, et al. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric 2008; 11: 422–8.
21. BenediktsdottirB, JansonC, LindbergE, et al. Prevalence of restless legs syndrome among adults in Iceland and Sweden: lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med 2010; 11: 1043–8.
22. BergerK, LuedemannJ, TrenkwalderC, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164: 196–202.
23. FoleyD, Ancoli-IsraelS, BritzP, et al. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004; 56: 497–502.
24. JuutiAK, LäärE, RajalaU, et al. Prevalence and associated factors of restless legs in a 57-year-old urban population in northern Finland. Acta Neurol Scand 2010; 122: 63–9.
25. WaltersAS, RyeDB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 2009; 32: 589–97.
26. Espinar-SierraJ, Vela-BuenoA, Luque-OteroM. Periodic leg movements in sleep in essential hypertension. Psychiatry Clin Neurosci 1997; 51: 103–7.
27. BillarsL, HicksA, BliwiseD, et al. Hypertension risk and PLMS in restless legs syndrome. Sleep 2007; 30: A297–8.
28. WingYK, ZhangJ, HoCK, et al. Periodic limb movement during sleep is associated with nocturnal hypertension in children. Sleep 2010; 33: 759–65.
29. HanlyP, Zuberi-KhokharN. Periodic limb movements during sleep in patients with congestive heart failure. Chest 1996; 109: 1497–502.
30. JavaheriS. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006; 106: 21–8.
31. SkomroR, SilvaR, AlvesR, et al. The prevalence and significance of periodic leg movements during sleep in patients with congestive heart failure. Sleep Breath 2009; 13: 43–7.
32. PennestriMH, MontplaisirJ, ColomboR, et al. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007; 68: 1213–18.
33. SforzaE, NicolasA, LavigneG, et al. EEG and cardiac activation during periodic leg movements in sleep: support for a hierarchy of arousal responses. Neurology 1999; 52: 786–91.
34. FerriR, ZucconiM, RundoF, et al. Heart rate and spectral EEG changes accompanying periodic and non-periodic leg movements during sleep. Clin Neurophysiol 2007; 118: 438–48.
35. SiddiquiF, StrusJ, MingX, et al. Rise of blood pressure with periodic limb movements in sleep and wakefulness. Clin Neurophysiol 2007; 118: 1923–30.
36. WinkelmanJW. The evoked heart rate response to periodic leg movements of sleep. Sleep 1999; 22: 575–80.
37. GuggisbergAG, HessCW, MathisJ. The significance of the sympathetic nervous system in the pathophysiology of periodic leg movements in sleep. Sleep 2007; 30: 755–66.
38. ManconiM, FerriR, ZucconiM, et al. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep. Sleep Med 2011; 12: 47–55.
39. SchillingC, SchredlM, StroblP, et al. Restless legs syndrome: evidence for nocturnal hypothalamic-pituitary-adrenal system activation. Mov Disord 2010; 25: 1047–52.
40. WetterTC, Collado-SeidelV, OertelH, et al. Endocrine rhythms in patients with restless legs syndrome. J Neurol 2002; 249: 146–51.
41. GangwischJE, HeymsfieldSB, Boden-AlbalaB, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006; 47: 833–9.
42. EguchiK, PickeringTG, SchwartzJE, et al. Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med 2008; 168: 2225–31.
43. SchlesingerI, ErikhI, AvizoharO, et al. Cardiovascular risk factors in restless legs syndrome. Mov Disord 2009; 24: 1587–92.
44. CosentinoFII, AricòD, LanuzzaB, et al. Absence of cardiovascular disease risk factors in restless legs syndrome. Acta Neurol Scand 2012; 125: 319–25.
45. HornyakM. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs 2010; 24: 89–98.
46. ProviniF, AntelmiE, VignatelliL, et al. Increased prevalence of nocturnal smoking in restless legs syndrome (RLS). Sleep Med 2010; 11: 218–20.
47. ProviniF, AntelmiE, VignatelliL, et al. Association of restless legs syndrome with nocturnal eating: a case-control study. Mov Disord 2009; 24: 871–7.